共 72 条
[1]
Newman TB(1996)Carcinogenicity of lipid-lowering drugs JAMA 275 55-60
[2]
Hulley SB(1996)The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators N Engl J Med 335 1001-1009
[3]
Sacks FM(2002)Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 1623-1630
[4]
Pfeffer MA(2002)HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508-519
[5]
Moye LA(2003)The statins as anticancer agents Clin Cancer Res 9 10-19
[6]
Shepherd J(2000)3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case–control study Arch Intern Med 160 2363-2368
[7]
Blauw GJ(2004)Statin use and cancer risk in the General Practice Research Database Br J Cancer 90 635-637
[8]
Murphy MB(2007)Statin use and the risk of 10 cancers Epidemiology 18 213-219
[9]
Wong WW(2005)Cancer risk among statin users: a population-based cohort study Int J Cancer 114 643-647
[10]
Dimitroulakos J(2008)Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients Pharmacoepidemiol Drug Saf 17 27-36